SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-19-009737
Filing Date
2019-03-28
Accepted
2019-03-28 12:27:35
Documents
3
Period of Report
2019-03-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A ovid-8ka_20190324.htm 8-K/A 32097
2 EX-99.1 ovid-ex991_6.htm EX-99.1 16978
3 GRAPHIC gycfa1p3qee0000001.jpg GRAPHIC 4373
  Complete submission text file 0001564590-19-009737.txt   56518
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38085 | Film No.: 19710882
SIC: 2834 Pharmaceutical Preparations